in the Arctic region, Copenhagen, Denmark, 22 23 March 2012 David FitzSimons, Brian McMahon, Greet Hendrickx*, Alex Vorsters and Pierre Van Damme Documentation and Communication, Office of Governing Bodies, World Health Organization, Geneva, Switzerland; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA; Viral Hepatitis Prevention Board (VHPB), Cent...

Non-travel-related hepatitis A is rare in Canada. We describe a hepatitis A outbreak investigation in British Columbia in February to May 2012 in which exposure history was collected from nine confirmed non-travel-related cases. Suspected foods were tested for hepatitis A virus (HAV): a frozen fruit blend was identified as a common exposure for six of the nine cases using supermarket loyalty ca...

Viral hepatitis and its acute and chronic complications continue to pose significant threats to the readiness of military personnel. Knowledge about the specific viral agents and their routes of transmission are important in developing prevention strategies. A recent analysis of hepatitis in the US Navy for the period 1975-1984 is reviewed. In order to better characterize the risk of viral hepa...

In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.

OBJECTIVES Although persons who inject drugs have high prevalence of hepatitis C virus (HCV) infection, few receive treatment mostly because of lack of knowledge about the infection and its treatment. We assessed the level of HCV-related knowledge and willingness to participate in HCV treatment among methadone-maintained patients. METHODS A 30-item survey covering HCV-related knowledge and wi...

The hepatitis database contains the results of laboratory examinations taken on the patients of hepatitis B and C during 1982-2001, and recently was given to challenge data mining research. This paper presents our approach to two problems of distinguishing hepatitis B and C, and the relations between laboratory data and fibrosis stages. The approach is based on temporal abstraction and the visu...

BACKGROUND Regular surveillance is recommended for patients with chronic hepatitis B, to select candidates for anti-viral therapy and detect early complications. However, factors that determine compliance are not well studied. AIM To determine the utility of the Health Belief Model in explaining non-compliance, among a group of chronic hepatitis B patients for screening. METHODS A total of ...

A unique presentation of perinatally acquired hepatitis C (HCV) with acute jaundice and chronic aggressive liver disease in a previously asymptomatic preadolescent is described. The difficulties in establishing the diagnosis and the importance of confirmatory testing for HCV in cryptogenic liver disease are discussed.

Viral hepatitis C is responsible for a large burden of disease worldwide. Treatment of hepatitis C infection is currently undergoing a revolution with the development of new direct acting antivirals that offer higher cure rates and fewer side effects than other medications currently available. Treatment options for children, although well-defined and evidence-based, are limited relative to adul...